Tag: retinopathy of prematurity (ROP)

Ophthalmic researchers Jonathan Sears, MD, and George Hoppe, MD, PhD

One Step Closer to a Drug Preventing Retinopathy of Prematurity

Artificially stabilizing hypoxia-inducible factor may stop the damaging effects of hyperoxia in preterm infants

20-EYE-1859529-CQD-Retinal-Metabolic-Remodeling

Why and How Hyperoxia Leads to Growth Suppression in Retinopathy of Prematurity

New study points to retinal metabolic remodeling and hepatic nitrogen imbalance

NEI ROP

The HIF Stabilizer Roxadustat Doesn’t Lead to Pathological Retinal Angiogenesis

New research sheds light on mechanism of action in ROP protection

19-EYE-726-ARVO-CQD

Meet Cole Eye Institute Experts at Our 2019 ARVO Booth Presentations

Learn about clinical, research advances at booth 713

Advertisement

Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy

16-EYE-2652-Sears-CQD-Hero

Stimulating Angiogenesis to Prevent Retinopathy of Prematurity

Researchers prove HIF proteins inhibit oxygen-induced retinopathy

650×450-Sears
April 13, 2016/Ophthalmology

Combating Retinopathy of Prematurity, the Most Common Cause of Childhood Blindness

Investigating stimulating liver to protect distal capillary beds and reduce ROP

BackPage 1 of 1Next
Advertisement
Ad